We’re Janssen, the pharmaceutical companies of Johnson & Johnson
At Janssen EMEA, we’re dedicated to tackling some of the most important public health issues across Europe, the Middle East and Africa.
We are uniquely positioned to benefit from the region’s world-leading scientific and political organisations, along with its diverse mix of countries.
We have 30 local offices, each with their own unique challenges, and all united by one shared vision: a future where disease is a thing of the past.
Janssen EMEA Facts
• Part of Janssen Global, one of the world’s top 10 pharmaceutical companies
• Active in over 150 countries throughout the world
• Offices in over 30 countries, across a region that stretches from Norway to South Africa, and from Russia to Ireland
• Janssen EMEA spends $1.5 billion a year on research and development
• Eight EMEA research centres
• Over 14,000 employees
Our Therapy Areas
We focus on six areas of medicine where the need is high, the science is compelling, and where we can make the biggest difference:
We want to transform lives by changing the way diseases are managed and prevented. We want to:
• Advance science to improve patient outcomes
• Collaborate with different partners to address key unmet needs
• Provide effective, affordable medicines
• Bring new hope for doctors and patientsLearn More
Everything we do is guided by Our Credo. It challenges us to put the needs and wellbeing of the people we serve first.
Janssen has always been forward-thinking. Our story is one of global firsts. From inventing BAND-AIDs® to developing the first antipsychotic medication , being cutting-edge has always been at the heart of what we do.
We know that the way healthcare is delivered is evolving fast, and we’re excited to be part of that change. From game-changing apps and first-in-class therapies to medical devices, we’re exploring beyond the conventional. That’s because we think being creative, ambitious and forward-focused is the best way to meet our goal of making disease a thing of the past.
JLABS is a global network of open innovation centres, that enables innovators across the healthcare spectrum to create and accelerate the delivery of lifesaving, life-enhancing health solutions to patients around the world.
The first JLAB in Europe, JLABS @ BE in Beerse, Belgium, is home to life science start-ups focused on innovations across the entire healthcare spectrum, including pharmaceuticals, medical devices, consumer and health technology.Jlabs
Johnson & Johnson has established Innovation Centres in the world’s top life science hubs, which are constantly working on new ideas for improving human health.
Our EMEA Innovation Centre in London is a regional hub for collaborations throughout Europe, the Middle East and Africa (EMEA), with networks in innovation hotspots, such as Switzerland, Scandinavia, France and Germany.Learn more
At Janssen, we work with external partners across our entire business because we think that collaborating is one of the best ways to develop solutions for patients, healthcare professionals and healthcare systems.
We partner with start-ups, universities, scientific organisations and government institutions, to name a few, because we know that great ideas can come from anywhere, not just from within our company.our Collaborations